Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

CAS 1585969-17-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 1585969-17-0
Also known as: 1954693-13-0, 1585969-17-0, 5-bromo-2-(5-bromo-2,3-dihydro-1h-indol-2-yl)phenol, Tqp0847, Bcp20018, Bcp20090
Molecular Formula
C14H11Br2NO
Molecular Weight
369.05  g/mol
InChI Key
UEUDUQLMNBTXFJ-UHFFFAOYSA-N

1 2D Structure

CAS 1585969-17-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-bromo-2-(5-bromo-2,3-dihydro-1H-indol-2-yl)phenol
2.1.2 InChI
InChI=1S/C14H11Br2NO/c15-9-2-4-12-8(5-9)6-13(17-12)11-3-1-10(16)7-14(11)18/h1-5,7,13,17-18H,6H2
2.1.3 InChI Key
UEUDUQLMNBTXFJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C(NC2=C1C=C(C=C2)Br)C3=C(C=C(C=C3)Br)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 1954693-13-0

2. 1585969-17-0

3. 5-bromo-2-(5-bromo-2,3-dihydro-1h-indol-2-yl)phenol

4. Tqp0847

5. Bcp20018

6. Bcp20090

7. Cs-b1724

8. Cs-15326

9. C13288

10. Phenol, 5-bromo-2-[(2r)-5-bromo-2,3-dihydro-1h-indol-2-yl]-

2.3 Create Date
2017-01-25
3 Chemical and Physical Properties
Molecular Weight 369.05 g/mol
Molecular Formula C14H11Br2NO
XLogP34.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass368.91869 g/mol
Monoisotopic Mass366.92074 g/mol
Topological Polar Surface Area32.3 Ų
Heavy Atom Count18
Formal Charge0
Complexity302
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
203314-28-7
Elbasvir
Ningbo Chemgoo is a R&D-driven company with core technology of organic chemistry, dedicating in technolog...
Ningbo Chemgoo is a R&D-driven company with core technology of organic chemistry, dedicating in technology development and industrialization. We provide intermediates from gram scale to hundreds of Kg to domestic and abroad customers in pharmaceutical area. The R&D center occupies around 3,000m2, equipped with gram scale labs, pilot labs, analysis center, safety assessment lab and platform for flow chemistry. The company has successfully developed more than 60 projects. The main products of Telmisartan intermediates widely win good reputation in markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY